Clinical Trial Update: Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray [Phase 3]

View source ↗

Summary

Phase 3 safety trial in children with seasonal and perennial allergic rhinitis evaluating GW685698X aqueous nasal spray versus placebo has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Perennial Allergic Rhinitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• GW685698X

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Perennial and Seasonal | Phase 3 | Status: COMPLETED